AUBREY RAUSCH: Open Payments
NPI 1447957337 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 76 payments from 34 companies in 2025. Trend: 2023 $117 · 2024 $896 · 2025 $1,911
Food & beverage: $1,911
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $216 |
| Merck Sharp & Dohme LLC | 8 | $205 |
| Novocure Inc. | 1 | $143 |
| SpringWorks Therapeutics, Inc. | 1 | $113 |
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| Myriad Genetic Laboratories, Inc. | 1 | $105 |
| GENZYME CORPORATION | 4 | $77 |
| TerSera Therapeutics LLC | 3 | $69 |
| ABBVIE INC. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
Products named: KEYTRUDA, Optune Lua (NovoTTF-200T), OGSIVEO, MYRISK, ENHERTU, SARCLISA, OPDIVO, KISQALI.
Industry payments across KS — which companies pay providers there.
